U.S. Drug Testing Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples), By Drug (Alcohol, Opioids), By End Use (Drug Testing Laboratories, Workplaces, Hospitals), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Sample type
                        1.2.3. Drug type
                        1.2.4. End use
                        1.2.5. Estimates and forecasts timeline
                    1.3. Objectives
                        1.3.1. Objective-1
                        1.3.2. Objective-2
                        1.3.3. Objective-3
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased database
                        1.5.2. GVR’s internal database
                        1.5.3. Secondary sources
                        1.5.4. Primary research
                    1.6. Information or Data Analysis
                        1.6.1. Data analysis models
                    1.7. Market Formulation & Validation
                    1.8. Model Details
                        1.8.1. Commodity flow analysis
                            1.8.1.1. Approach 1: Commodity flow approach
                            1.8.1.2. Approach 2: Country-wise market estimation using bottom-up approach
                    1.9. List of Secondary Sources
                    1.10. List of Primary Sources
                    1.11. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Product Snapshot
                    2.3. Sample Snapshot
                    2.4. Drug and End-use Snapshot
                    2.5. Competitive Insights
Chapter 3. U.S. Drug Testing Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook (Drug Testing Market)
                        3.1.2. Related/ancillary market outlook (Drug Screening Market)
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Rising prevalence of substance abuse
                            3.2.1.2. Stringent regulations requiring drug and alcohol testing
                            3.2.1.3. Growing government efforts to curb substance abuse
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Stringent regulatory framework for drug testing products
                        3.2.3. Market Opportunity Analysis
                            3.2.3.1. Expansion of testing in new industries
                            3.2.3.2. Policies like the Affordable Care Act (ACA)
                        3.2.4. Market Challenge Analysis
                            3.2.4.1. Economic Downturns
                            3.2.4.2. Reduction in corporate spending
                    3.3. U.S. Drug Testing Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Bargaining power of suppliers
                            3.3.1.2. Bargaining power of buyers
                            3.3.1.3. Threat of substitutes
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Economic landscape
                            3.3.2.3. Social landscape
                            3.3.2.4. Technological landscape
                            3.3.2.5. Environmental landscape
                            3.3.2.6. Legal landscape
                    3.4. Regulatory Framework
                    3.5. Reimbursement Scenario
Chapter 4. U.S. Drug Testing Market: Product Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Drug Testing Market: Product Movement Analysis
                    4.3. U.S. Drug Testing Market by Product Outlook (USD Million)
                    4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                    4.5. Consumables
                        4.5.1. Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.5.2. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.6. Instruments
                        4.6.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.6.2. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.7. Rapid Testing Devices
                        4.7.1. Rapid Testing Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.7.2. Rapid Testing Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.8. Services
                        4.8.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.8.2. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Drug Testing Market: Sample Type Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Drug Testing Market: Sample Type Movement Analysis
                    5.3. U.S. Drug Testing Market by Sample Type Outlook (USD Million)
                    5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                    5.5. Urine Samples
                        5.5.1. Urine Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.5.2. Urine Samples Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
                    5.6. Oral Fluid Samples
                        5.6.1. Oral Fluid Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.6.2. Oral Fluid Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.7. Hair Samples
                        5.7.1. Hair Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.7.2. Hair Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.8. Other Sample
                        5.8.1. Other Sample Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.8.2. Other Sample Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Drug Testing Market: Drug Type Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Drug Testing Market: Drug Type Movement Analysis
                    6.3. U.S. Drug Testing Market by Drug Type Outlook (USD Million)
                    6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                    6.5. Alcohol
                        6.5.1. Alcohol Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.2. Alcohol Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.6. Cannabis/Marijuana
                        6.6.1. Cannabis/Marijuana Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.2. Cannabis/Marijuana Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.7. Cocaine
                        6.7.1. Cocaine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.7.2. Cocaine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.8. Opioids
                        6.8.1. Opioids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.8.2. Opioids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.9. Amphetamine & Methamphetamine
                        6.9.1. Amphetamine & Methamphetamine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.9.2. Amphetamine & Methamphetamine Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
                    6.10. LSD
                        6.10.1. LSD Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.10.2. LSD Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
                    6.11. Others
                        6.11.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.11.2. Others Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
Chapter 7. U.S. Drug Testing Market: End Use Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. U.S. Drug Testing Market: End Use Movement Analysis
                    7.3. U.S. Drug Testing Market by End Use Outlook (USD Million)
                    7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                    7.5. Drug Testing Laboratories
                        7.5.1. Drug Testing Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.5.2. Drug Testing Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
                    7.6. Workplaces
                        7.6.1. Workplaces Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.6.2. Workplaces Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
                    7.7. Hospitals
                        7.7.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.7.2. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
                    7.8. Others
                        7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.8.2. Others Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
Chapter 8. Competitive Landscape
                    8.1. Market Participant Categorization
                    8.2. Recent Developments & Impact Analysis by Key Market Participants
                    8.3. Company Market Share Analysis, 2025
                    8.4. Key Company Profiles
                        8.4.1. Quest Diagnostics Incorporated
                            8.4.1.1. Company overview
                            8.4.1.2. Financial performance
                            8.4.1.3. Product benchmarking
                            8.4.1.4. Strategic initiatives
                        8.4.2. Abbott
                            8.4.2.1. Company overview
                            8.4.2.2. Financial performance
                            8.4.2.3. Product benchmarking
                            8.4.2.4. Strategic initiatives
                        8.4.3. Laboratory Corporation of America Holdings (Labcorp)
                            8.4.3.1. Company overview
                            8.4.3.2. Financial performance
                            8.4.3.3. Product benchmarking
                            8.4.3.4. Strategic initiatives
                        8.4.4. Thermo Fisher Scientific, Inc.
                            8.4.4.1. Company overview
                            8.4.4.2. Financial performance
                            8.4.4.3. Product benchmarking
                            8.4.4.4. Strategic initiatives
                        8.4.5. OraSure Technologies, Inc.
                            8.4.5.1. Company overview
                            8.4.5.2. Financial performance
                            8.4.5.3. Product benchmarking
                            8.4.5.4. Strategic initiatives
                        8.4.6. Psychemedics Corporation
                            8.4.6.1. Company overview
                            8.4.6.2. Financial performance
                            8.4.6.3. Product benchmarking
                            8.4.6.4. Strategic initiatives
                        8.4.7. Omega Laboratories, Inc
                            8.4.7.1. Company overview
                            8.4.7.2. Financial performance
                            8.4.7.3. Product benchmarking
                            8.4.7.4. Strategic initiatives
                        8.4.8. Premier Biotech, Inc
                            8.4.8.1. Company overview
                            8.4.8.2. Financial performance
                            8.4.8.3. Product benchmarking
                            8.4.8.4. Strategic initiatives
                        8.4.9. Alfa Scientific Designs, Inc
                            8.4.9.1. Company overview
                            8.4.9.2. Financial performance
                            8.4.9.3. Product benchmarking
                            8.4.9.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. drug testing market, by product, 2021 - 2033 (USD Million)
Table 4 U.S. drug testing market, by sample, 2021 - 2033 (USD Million)
Table 5 The detection span for drugs using urine samples
Table 6 The detection span for drugs using oral fluid samples
Table 7 The detection span for drugs using hair samples
Table 8 U.S. drug testing market, by drug, 2021 - 2033 (USD Million)
Table 9 U.S. drug testing market, by end use, 2021 - 2033 (USD Million)
Table 10 Key players involved in mergers and acquisitions
Table 11 Key players involved in partnerships and collaboration
Table 12 Key players involved in new product launch
Table 13 Key players involved in other strategies

List of Figures

Fig. 1 U.S. drug testing market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. drug testing market snapshot
Fig. 10 Test snapshot
Fig. 11 Application and end-use snapshot
Fig. 12 Competitive landscape snapshot
Fig. 13 Parent market outlook
Fig. 14 Related/ancillary market outlook
Fig. 15 Market dynamics
Fig. 16 Market driver analysis (current & future impact)
Fig. 17 Market restraint analysis (current & future impact)
Fig. 18 Porter’s five forces analysis
Fig. 19 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 20 Industry analysis - Porter’s
Fig. 21 U.S. drug testing market Product outlook key takeaways
Fig. 22 U.S. drug testing market, Product movement analysis
Fig. 23 Consumables market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 24 Instruments market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 25 Rapid testing devices market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 26 Services market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 27 U.S. drug testing market: Sample type outlook and key takeaways
Fig. 28 U.S. drug testing market: Sample type movement analysis
Fig. 29 Urine samples market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 30 Oral fluid samples market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 31 Hair samples market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 32 Other sample market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 33 U.S. drug testing market: Drug type outlook and key takeaways
Fig. 34 U.S. drug testing market: Drug type movement analysis
Fig. 35 Alcohol market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 36 Cannabis/Marijuana market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 37 Cocaine market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 38 Opioids market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 39 Amphetamine & methamphetamine market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 40 LSD market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 41 LSD drug use in the past year among people aged 12 or older; by age group, 2021, in U.S.
Fig. 42 Others market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 43 U.S. drug testing market: End use outlook and key takeaways
Fig. 44 U.S. drug testing market: End use movement analysis
Fig. 45 Drug testing laboratories market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 46 Workplaces market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 47 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 48 Others market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 49 Alcohol use disorder diagnose among age groups
Fig. 50 Key company categorization
Fig. 51 U.S. drug testing market share analysis, 2025
Fig. 52 Strategy mapping